tiprankstipranks
Advertisement
Advertisement

ARVN Stock Latest News

Arvinas price target lowered to $10 from $11 at Morgan Stanley
The FlyArvinas price target lowered to $10 from $11 at Morgan Stanley
11d ago
ARVN
Arvinas price target lowered to $14 from $19 at Evercore ISI
PremiumThe Fly
Arvinas price target lowered to $14 from $19 at Evercore ISI
11d ago
ARVN
Arvinas price target lowered to $21 from $24 at Citi
PremiumThe Fly
Arvinas price target lowered to $21 from $24 at Citi
11d ago
ARVN
Arvinas Launches New Cancer Combo Trial, Adding Fresh Optionality to ARVN
PremiumCompany Announcements
Arvinas Launches New Cancer Combo Trial, Adding Fresh Optionality to ARVN
14d ago
ARVN
Arvinas price target raised to $12 from $11 at Wedbush
PremiumThe Fly
Arvinas price target raised to $12 from $11 at Wedbush
15d ago
ARVN
Arvinas Holding Earnings Call: PROTAC Milestone and Outlook
PremiumCompany AnnouncementsArvinas Holding Earnings Call: PROTAC Milestone and Outlook
16d ago
ARVN
Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027
Premium
The Fly
Wells downgrades Arvinas to Equal Weight, sees catalysts coming in 2027
16d ago
ARVN
Arvinas downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Arvinas downgraded to Equal Weight from Overweight at Wells Fargo
16d ago
ARVN
Arvinas reports Q2 EPS $2.58, consensus (28c)
PremiumThe Fly
Arvinas reports Q2 EPS $2.58, consensus (28c)
17d ago
ARVN
Is ARVN a Buy, Before Earnings?
PremiumPre-Earnings
Is ARVN a Buy, Before Earnings?
19d ago
ARVN
Arvinas Shareholders Back Directors, Pay and Auditor Choices
PremiumCompany Announcements
Arvinas Shareholders Back Directors, Pay and Auditor Choices
2M ago
8K
ARVN
Arvinas Announces Chief Medical Officer Leadership Transition
PremiumCompany Announcements
Arvinas Announces Chief Medical Officer Leadership Transition
2M ago
8K
ARVN
Rigel Deal for VEPPANU Cleared, Arvinas Receives Payment
PremiumCompany AnnouncementsRigel Deal for VEPPANU Cleared, Arvinas Receives Payment
2M ago
8K
ARVN
Rigel closes license agreement for Veppanu
Premium
The Fly
Rigel closes license agreement for Veppanu
2M ago
PFE
ARVN
Arvinas Reprioritizes Pipeline, Out-Licenses ARV-806 Development
Premium
Company Announcements
Arvinas Reprioritizes Pipeline, Out-Licenses ARV-806 Development
3M ago
8K
ARVN
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe Fly
Citizens biotech analysts hold a dinnermeeting at ASCO
3M ago
AZN
LLY
Arvinas Earnings Call: VEPPANU Win, Pipeline Momentum
PremiumCompany Announcements
Arvinas Earnings Call: VEPPANU Win, Pipeline Momentum
3M ago
ARVN
Arvinas price target raised to $16 from $14 at BofA
PremiumThe Fly
Arvinas price target raised to $16 from $14 at BofA
3M ago
PFE
ARVN
Arvinas Buy Rating Reiterated as Analyst Highlights Pipeline Optionality and VEPPANU Deal, Maintains $18 Price Target
PremiumRatings
Arvinas Buy Rating Reiterated as Analyst Highlights Pipeline Optionality and VEPPANU Deal, Maintains $18 Price Target
3M ago
ARVN
Arvinas price target raised to $18 from $16 at BTIG
PremiumThe FlyArvinas price target raised to $18 from $16 at BTIG
3M ago
ARVN
RIGL
Arvinas price target raised to $20 from $18 at Barclays
Premium
The Fly
Arvinas price target raised to $20 from $18 at Barclays
3M ago
ARVN
Arvinas Faces Key Commercialization Risk as VEPPANU’s Success Hinges on Third‑Party Partner with Pfizer
Premium
Company Announcements
Arvinas Faces Key Commercialization Risk as VEPPANU’s Success Hinges on Third‑Party Partner with Pfizer
3M ago
ARVN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >